Trials / Completed
CompletedNCT06497517
A Study to Investigate the Effect of Food on Camlipixant Concentrations in Healthy Participants
A Phase 1, Single Center, Single Dose, Open-Label, Randomized, 2-Way Crossover Study to Investigate the Food Effect on the Pharmacokinetics of Camlipixant in Healthy Male and Female Participants
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 14 (actual)
- Sponsor
- Bellus Health Inc. - a GSK company · Industry
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
This study is a single center, single dose, open-label, randomly assigned 2-way crossover study. The study will investigate the food effect on the pharmacokinetics of Camlipixant (GSK5464714) in healthy male and female participants. Eligible participants will be randomized to pre-defined sequences. There will be a washout of minimum 7 days between each dose of treatment period.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | GSK5464714- Camlipixant | GSK5464714- Camlipixant will be administered |
Timeline
- Start date
- 2024-07-09
- Primary completion
- 2024-08-22
- Completion
- 2024-08-26
- First posted
- 2024-07-11
- Last updated
- 2025-02-07
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT06497517. Inclusion in this directory is not an endorsement.